KRT17 and cervical cancer: The extracted data of these two genes’ expression in GEO datasets suggested the same tendency (Figure 5), so that means that combination of KRT17 and CRISP2 may be used as diagnostic biomarker to distinguish the different histologic grades of cervical cancer.